Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing

Autor: Raquel Pérez-Robles, Antonio Salmerón-García, Jesus Hermosilla, Anabel Torrente-López, Susana Clemente-Bautista, Inés Jiménez-Lozano, María Josep Cabañas-Poy, Jose Cabeza, Natalia Navas

Publikováno v: Scientia

Physico-chemical characterization; Stress testing; Teduglutide Caracterització fisicoquímica; Proves d'estrès; Teduglutida Caracterización físicoquímica; Pruebas de estrés; Teduglutida Teduglutide (Revestive®) is a glucagon-like peptide-2 ana

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12bc99c7986e8a8e4bafb4272bea8e19
https://hdl.handle.net/11351/9216

Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS

Autor: Raquel Pérez-Robles, Antonio Salmerón-García, Susana Clemente-Bautista, Inés Jiménez-Lozano, María Josep Cabañas-Poy, Jose Cabeza, Natalia Navas

Publikováno v: Scientia

Peptide; Teduglutide; Short bowel syndrome Pèptid; Teduglutida; Síndrome de l'intestí curt Péptido; Teduglutida; Síndrome del intestino corto Teduglutide (Revestive®, 10 mg mL−1) is a recombinant human glucagon-like peptide 2 analogue, used i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ece306adb6c29cc4ee6fc9960e86f8
https://hdl.handle.net/10668/19643

3D printed personalized therapies for pediatric patients affected by adrenal insufficiency.

Autor: Rodríguez-Pombo L; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Gallego-Fernández C; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Jørgensen AK; Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK., Parramon-Teixidó CJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Cañete-Ramirez C; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Cabañas-Poy MJ; Pharmacy Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Basit AW; Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK.; FABRX Ltd., Henwood House, Henwood, Ashford, Kent, UK.; FABRX Artificial Intelligence, Carretera de Escairón, 14, Currelos (O Saviñao), Spain., Alvarez-Lorenzo C; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain., Goyanes A; Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, I+D Farma (GI-1645), Facultad de Farmacia, Instituto de Materiales (iMATUS) and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.; Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK.; FABRX Ltd., Henwood House, Henwood, Ashford, Kent, UK.; FABRX Artificial Intelligence, Carretera de Escairón, 14, Currelos (O Saviñao), Spain.

Publikováno v: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2024 Nov; Vol. 21 (11), pp. 1665-1681. Date of Electronic Publication: 2024 Sep 18.

Physical Compatibility Between Intravenous Magnesium Sulfate and Potassium or Sodium Phosphate in a Pediatric Intensive Care Unit.

Autor: Clemente Bautista S; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Jiménez Lozano I; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Castellote Belles L; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona, Spain., Parramón-Teixidó CJ; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Garcia Esquerda C; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Puertas Sanjuan A; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain., Daina Noves C; Pediatric Critical Care Department, Vall d'Hebron University Hospital, Barcelona, Spain., Segura Encinas V; Pediatric Critical Care Department, Vall d'Hebron University Hospital, Barcelona, Spain., Cabañas Poy MJ; Pharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain.

Publikováno v: Hospital pharmacy [Hosp Pharm] 2024 Oct; Vol. 59 (5), pp. 557-561. Date of Electronic Publication: 2024 Apr 15.

Case Report: Micafungin for treating Candida glabrata urinary infection: a clinical case in a premature neonate.

Autor: Parramon-Teixido CJ; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain., Garcia Esquerda C; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain., Frick MA; Division of Infectious Diseases and Pediatric Immunology, Department of Pediatrics, Vall d'Hebron University Hospital, Barcelona, Spain., Tripodi C; Department of Neonatology, Dr. Josep Trueta University Hospital of Girona, Girona, Spain., Gomez-Ganda L; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain., Ruiz-Campillo CW; Department of Neonatology, Vall d'Hebron University Hospital, Barcelona, Spain., Cabañas-Poy MJ; Department of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.

Publikováno v: Frontiers in pediatrics [Front Pediatr] 2024 May 17; Vol. 12, pp. 1397456. Date of Electronic Publication: 2024 May 17 (Print Publication: 2024).